Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Other Non Operating Income (2018 - 2024)

International Stem Cell (ISCO) has disclosed Other Non Operating Income for 6 consecutive years, with $5000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Other Non Operating Income fell 37.5% to $5000.0 in Q2 2024 year-over-year; TTM through Jun 2024 was -$650000.0, a 241.92% decrease, with the full-year FY2023 number at $8000.0, up 161.54% from a year prior.
  • Other Non Operating Income was $5000.0 for Q2 2024 at International Stem Cell, up from -$663000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $661000.0 in Q2 2021 to a low of -$663000.0 in Q3 2023.
  • A 4-year average of $59250.0 and a median of $6500.0 in 2023 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: plummeted 8187.5% in 2023, then plummeted 37.5% in 2024.
  • International Stem Cell's Other Non Operating Income stood at $463000.0 in 2021, then tumbled by 101.08% to -$5000.0 in 2022, then plummeted by 13160.0% to -$663000.0 in 2023, then skyrocketed by 100.75% to $5000.0 in 2024.
  • Per Business Quant, the three most recent readings for ISCO's Other Non Operating Income are $5000.0 (Q2 2024), -$663000.0 (Q3 2023), and $8000.0 (Q2 2023).